au.\*:("MENARD, Sylvie")
Results 1 to 25 of 46
Selection :
Les Églises et la prise en charge de l'enfance au Québec: le cas des institutions d'enfermement pour les jeunes délinquants ou en danger (1858-1950) = Churches and the policy of childhood in Quebec: youth internmentMENARD, Sylvie.Etudes d'histoire religieuse. 2003, pp 69-82, issn 1193-199X, 14 p.Article
L'institut Saint-Antoine et la question de l'institutionnalisation des mineurs au Québec (1869-1950) : La jeunesse au Québec. Marges, institutions et représentations = The institut saint-antoine and the question of the institutionalization of minors in quebec (1869-1950)MENARD, Sylvie.Globe (Montréal.1998). 2005, Vol 8, Num 2, pp 73-90, issn 1481-5869, 18 p.Article
Molecular phenotype distinguishes two subsets of gastric low-grade mucosa-associated lymphoid tissue lymphomasNARDINI, Elena; RIZZI, Simona; MENARD, Sylvie et al.Laboratory investigation. 2002, Vol 82, Num 5, pp 535-541, issn 0023-6837Article
Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograftPRATESI, Graziella; PETRANGOLINI, Giovanna; TORTORETO, Monica et al.Cancer research (Baltimore). 2005, Vol 65, Num 14, pp 6388-6393, issn 0008-5472, 6 p.Article
Immunological and pathobiological roles of fibulin-1 in breast cancerPUPA, Serenella M; ARGRAVES, Scott W; MORTARINI, Roberta et al.Oncogene (Basingstoke). 2004, Vol 23, Num 12, pp 2153-2160, issn 0950-9232, 8 p.Article
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2GENNARI, Roberto; MENARD, Sylvie; OLIVIERO, Barbara et al.Clinical cancer research. 2004, Vol 10, Num 17, pp 5650-5655, issn 1078-0432, 6 p.Article
Role of proliferation in HER2 status predicted response to doxorubicinCAMPIGLIO, Manuela; SOMENZI, Giulia; OLGIATI, Clelia et al.International journal of cancer. 2003, Vol 105, Num 4, pp 568-573, issn 0020-7136, 6 p.Article
SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitroORLANDI, Rosaria; CATTANEO, Monica; TROGLIO, Flavia et al.Cancer research (Baltimore). 2002, Vol 62, Num 2, pp 567-574, issn 0008-5472Article
Sex Hormone Levels, Breast Cancer Risk, and Cancer Receptor Status in Postmenopausal Women : the ORDET CohortSIERI, Sabina; KROGH, Vittorio; SCHUNEMANN, Holger J et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 1, pp 169-176, issn 1055-9965, 8 p.Article
Antitumor Efficacy of Trastuzumab in Nude Mice Orthotopically Xenografted With Human Pancreatic Tumor Cells Expressing Low Levels of HER-2/neuPRATESI, Graziella; PETRANGOLINI, Giovanna; TORTORETO, Monica et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 6, pp 537-544, issn 1524-9557, 8 p.Article
MicroRNA signatures in human ovarian cancerIORIO, Marilena V; VISONE, Rosa; CALIN, George A et al.Cancer research (Baltimore). 2007, Vol 67, Num 18, pp 8699-8707, issn 0008-5472, 9 p.Article
Enfant sujet, enfant objet ? L'enfant comme enjeu des nouvelles politiques pénales au Québec, de la seconde moitié du XIXesiècle au début du XXe siècle = Is the child a subject or an object ? The child as the focus of new policies on criminality in Quebec, from the second half of the 19th century to the beginning of the 20th centuryMENARD, Sylvie; STRIMELLE, Véronique.Lien social et politiques, RIAC. 2000, Num 44, pp 89-99, issn 1204-3206, 179 [12 p.]Article
The HER2 World: Better Treatment Selection for Better OutcomeTAGLIABUE, Elda; CAMPIGLIO, Manuela; PUPA, Serenella M et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 82-85, issn 1052-6773, 4 p.Conference Paper
MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancerIORIO, Marilena V; CASALINI, Patrizia; TAGLIABUE, Elda et al.European journal of cancer (1990). 2008, Vol 44, Num 18, pp 2753-2759, issn 0959-8049, 7 p.Article
Elements Related to Heterogeneity of Antibody-Dependent Cell Cytotoxicity in Patients Under Trastuzumab Therapy for Primary Operable Breast Cancer Overexpressing Her2VARCHETTA, Stefania; GIBELLI, Nadia; COSTA, Alberto et al.Cancer research (Baltimore). 2007, Vol 67, Num 24, pp 11991-11999, issn 0008-5472, 9 p.Article
Linking survival of HER2-positive breast carcinoma patients with surgical invasivenessTAGLIABUE, Elda; AGRESTI, Roberto; CASALINI, Patrizia et al.European journal of cancer (1990). 2006, Vol 42, Num 8, pp 1057-1061, issn 0959-8049, 5 p.Article
SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro and in vivoCATTANEO, Monica; ORLANDINI, Simonetta; MENARD, Sylvie et al.Oncogene (Basingstoke). 2003, Vol 22, Num 41, pp 6359-6368, issn 0950-9232, 10 p.Article
HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviorsMENARD, Sylvie; BALSARI, Andrea; CASALINI, Patrizia et al.Clinical cancer research. 2002, Vol 8, Num 2, pp 520-525, issn 1078-0432Article
Axillary Lymph Node Dissection Versus No Dissection in Patients With T1NO Breast Cancer: A Randomized Clinical Trial (INT09/98)AGRESTI, Roberto; MARTELLI, Gabriele; BIANCHI, Giulia et al.Cancer. 2014, Vol 120, Num 6, pp 885-893, issn 0008-543X, 9 p.Article
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective studyCAMPIGLIO, Manuela; BUFALINO, Rosaria; BOTTINI, Alberto et al.Breast cancer research and treatment. 2011, Vol 128, Num 1, pp 147-154, issn 0167-6806, 8 p.Article
Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signalingNORMANNO, Nicola; CAMPIGLIO, Manuela; MAIELLO, Monica R et al.Breast cancer research and treatment. 2008, Vol 112, Num 1, pp 25-33, issn 0167-6806, 9 p.Article
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccinationPUPA, Serenella M; IEZZI, Manuela; DI CARLO, Emma et al.Cancer research (Baltimore). 2005, Vol 65, Num 3, pp 1071-1078, issn 0008-5472, 8 p.Article
MicroRNA gene expression deregulation in human breast cancerIORIO, Marilena V; FERRACIN, Manuela; MENARD, Sylvie et al.Cancer research (Baltimore). 2005, Vol 65, Num 16, pp 7065-7070, issn 0008-5472, 6 p.Article
CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory responseSFONDRINI, Lucia; BESUSSO, Dario; BRONTE, Vincenzo et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 8, pp 697-704, issn 0340-7004, 8 p.Article
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancerMOLITERNI, Angela; MENARD, Sylvie; BONADONNA, Gianni et al.Journal of clinical oncology. 2003, Vol 21, Num 3, pp 458-462, issn 0732-183X, 5 p.Article